The numbers behind chronic kidney disease in the Philippines are large enough to lose a person in: 13 million Filipinos affected, ₱592.15 billion in nationwide cost, more than half of that driven by patients who are diagnosed too late.
In a recent media kapihan organized by Boehringer Ingelheim, the people working closest to those numbers took the floor, not to repeat the statistics, but to explain what they mean for the patients behind them.
The event brought together three patient and medical advocacy groups: Kidney Alliance Philippines Inc., the Kidney Transplant Association of the Philippines (KITAP), and the Philippine Alliance of Patient Organizations (PAPO). Speakers included Randy Fernandez and Emaruth Blas of Kidney Alliance Philippines, Norina G. Gonzales and Grace Aquino of KITAP, and Nelia Medina and Isidora Duran of PAPO, alongside the voices below.
What early detection actually costs, and saves
Early-stage CKD care costs an estimated ₱42,000 a year. Late-stage disease climbs past ₱100,000. Dialysis runs about ₱560,000 annually, and a kidney transplant costs roughly ₱1.9 million. Complications add further strain: heart failure alone can add over ₱214,000 to a patient’s yearly costs.
A policy gap for young patients
Janneth Magyawi, treasurer of Kidney Alliance Philippines Inc., raised a concern that current CKD conversations tend to center on adult patients. “Most of the screening guidelines and awareness campaigns we see are built around adults,” Magyawi said. “I hope future policies make space for children too, because pediatric CKD exists, and families dealing with it often have nowhere clear to turn.”
Access after diagnosis
Abraham B. Mirandilla Jr., president of KITAP, spoke to the gap between the number of patients who need a transplant and the number who receive one. “Transplant changes a patient’s life, but access is still uneven,” Mirandilla said. “Part of what we do is help patients understand the process is possible, and help them prepare for it practically, not just medically.”
The unseen work of caregiving, and fighting misinformation online
Marimel Lamsin, treasurer of the Philippine Alliance of Patient Organizations, spoke about two sides of patient support that rarely make it into official statistics: the people caring for CKD patients, and the misinformation those families run into online. “We talk a lot about the patient, but caregivers carry a weight of their own, and burnout among them is real,” Lamsin said. “Part of our role is making sure they are not forgotten in the support system.”
Lamsin also pointed to social media as an increasingly urgent front for patient organizations. “A lot of what families read online about kidney disease is wrong, whether it is a miracle cure or bad advice about diet,” she said. “Correcting that misinformation, calmly and consistently, has become as much a part of our job as anything else we do.”
A shared throughline
Across the organizations present, the workshop returned to the same point made in Boehringer Ingelheim’s cost-of-illness data: chronic kidney disease is a silent, progressive condition, and the cost of catching it late is not only medical, but financial and personal. The speakers’ work, in their telling, is less about a single event and more about building a network sturdy enough to catch patients, and support the people around them, before that cost compounds.
About The Author
